VeriSeq™ NIPT: The New Standard in Prenatal Screening

June 3, 2019

If you think noninvasive prenatal testing (NIPT) is too complicated, think again. Discover VeriSeq NIPT, a different approach from Illumina. Built on industry-leading technology, the solution is simple, fast, and automated. Transform your lab with the revolutionary workflow. For In Vitro Diagnostic Use. Not available in all countries and regions. QB 5701 Subscribe to the Illumina video channel A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. Illumina, Inc., 2015. View customer spotlight videos View Illumina webinars View Illumina product videos View Illumina support videos

Share this article on